Present and future of FDG-PET/CT in ovarian cancer

Kazuhiro Kitajima, Koji Murakami, Setsu Sakamoto, Yasushi Kaji, Kazuro Sugimura

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

Original languageEnglish
Pages (from-to)155-164
Number of pages10
JournalAnnals of Nuclear Medicine
Volume25
Issue number3
DOIs
Publication statusPublished - 2011 Apr

    Fingerprint

Keywords

  • FDG
  • Ovarian cancer
  • PET/CT
  • Restaging
  • Staging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kitajima, K., Murakami, K., Sakamoto, S., Kaji, Y., & Sugimura, K. (2011). Present and future of FDG-PET/CT in ovarian cancer. Annals of Nuclear Medicine, 25(3), 155-164. https://doi.org/10.1007/s12149-010-0449-8